{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:16:34Z","timestamp":1784715394129,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"crossref","award":["UMO-2018\/29\/B\/NZ5\/02629"],"award-info":[{"award-number":["UMO-2018\/29\/B\/NZ5\/02629"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetes mellitus (DM) has been shown to increase the rate of aortic stenosis (AS) progression. However, the impact of impaired plasma glucose on valvular calcification remains poorly understood. Using ex vivo micro-computed tomography (micro-CT), we aimed to determine whether plasma glucose, glycated haemoglobin (HbA<jats:sub>1c<\/jats:sub>), or concentrations of advanced glycation end products (AGEs) and their soluble receptor (sRAGE) are associated with a specific pattern of valvular calcification in severe AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this case-control study, 14 (48%) normoglycaemic patients with AS were compared to 15 individuals (52%) with elevated glucose levels (\u2265\u20095.6 mmol\/L), all with HbA<jats:sub>1c<\/jats:sub>\u2009\u2264\u20096.5%. Stenotic aortic valves obtained surgically were analysed using micro-CT to assess structure of tissue mineralization. Calcium volume (CV), surface volume (SV), CV\/SV ratio, and trabecular thickness (TbTh) were evaluated. Plasma AGEs and sRAGE were assessed by ELISAs. DM patients or those using antidiabetic agents were excluded from the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients with impaired and high glucose, including 10 (67%) with glucose between 5.6 and 6.9 mmol\/L and 5 (33%) ranging from 7 to 7.6 mmol\/L, exhibited higher HbA<jats:sub>1c<\/jats:sub> (+\u200917%) and AGEs levels (+\u200944.6%), but not sRAGE compared to those with normal glucose. Patients with impaired and high glucose had also 19.2% higher maximal transvalvular pressure gradient (PG<jats:sub>max<\/jats:sub>) and 9.3% higher peak transvalvular velocity (V<jats:sub>max<\/jats:sub>) compared to normoglycaemic individuals. Micro-CT indices correlated with fasting glucose, HbA<jats:sub>1c<\/jats:sub>, and AGEs levels (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), but not with sRAGE (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Valves extracted from patients with impaired and high glucose exhibited higher mineralization volume, folding, and structural integrity, as reflected by increased CV (+\u2009127.6%), CV\/SV ratio (+\u200959%) and calcium deposits microarchitecture as indicated by about 50% higher TbTh, compared to normoglycaemic patients. When patients with AS were divided into three groups based on their glucose levels (&lt;\u20095.5 mmol\/L, 5.6\u20136.9 mmol\/L, and 7.0\u20137.6 mmol\/L), micro-CT analysis showed more distinct structural differences among the groups. The valves in the highest glucose group were the most severely affected. Micro-CT parameters were also associated with both transvalvular pressure gradients (PG<jats:sub>mean<\/jats:sub> and PG<jats:sub>max<\/jats:sub>), V<jats:sub>max<\/jats:sub> and aortic valve area (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Strict glycaemic control could potentially reduce the rate of valve mineralization and calcium deposit accumulation in patients with AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n            <jats:p>Pre-diabetic AS patients showed greater AS severity as measured by echocardiography, increased AGEs concentrations, and increased valvular calcification. Micro-CT parameters correlated with fasting glucose, HbA<jats:sub>1c<\/jats:sub>, AGEs concentrations, and disease severity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Research insights<\/jats:title>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>What is currently known about this topic?<\/jats:title>\n            <jats:p>Diabetes mellitus (DM) is a risk factor for the progression of aortic stenosis (AS). Accumulation of advanced glycation end products (AGEs) enhances glycation of valvular proteins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>What is the key research question?<\/jats:title>\n            <jats:p>Is dysglycaemia associated with more severe aortic valve calcification in patients with severe AS? Is ex vivo micro-CT suitable for assessing differences in calcification pattern within stenoticvalves?<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>What is new?<\/jats:title>\n            <jats:p>Pre-diabetic patients with AS show increased valvular calcium volume, surface corrugation, and calcium deposit integrity. Micro-CT parameters associate with glycaemic status and echocardiographic measures of AS severity. Micro-CT provides precise assessment of calcification, offering insights beyond traditional methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>How might this study influence clinical practice?<\/jats:title>\n            <jats:p>Strict glycaemic control together with CT calcium scoring should be performed in patients with AS to monitor disease progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02691-y","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:46:57Z","timestamp":1742489217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dysglycaemia is associated with the pattern of valvular calcification in micro-computed tomography analysis: an observational study in patients with severe aortic stenosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Magdalena","family":"Kopytek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila W.","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Tarasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wro\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Z\u0105bczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Natorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"4","key":"2691_CR1","first-page":"e1","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee, et al. 2025 heart disease and stroke statistics: a report of US and global data from the American heart association. Circulation. 2025;151(4):e1\u201312.","journal-title":"Circulation"},{"issue":"25","key":"2691_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2691_CR3","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1097\/MS9.0000000000002106","volume":"86","author":"H Jain","year":"2024","unstructured":"Jain H, Goyal A, Khan ATMA, Khan NU, Jain J, Chopra S, et al. Insights into calcific aortic valve stenosis: a comprehensive overview of the disease and advancing treatment strategies. Ann Med Surg (Lond). 2024;86(6):3577\u201390.","journal-title":"Ann Med Surg (Lond)"},{"issue":"17","key":"2691_CR4","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","volume":"113","author":"R Katz","year":"2006","unstructured":"Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic study of atherosclerosis. Circulation. 2006;113(17):2113\u20139.","journal-title":"Circulation"},{"issue":"10","key":"2691_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.33963\/KP.a2021.0137","volume":"79","author":"J Natorska","year":"2021","unstructured":"Natorska J. Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications. Kardiol Pol. 2021;79(10):1060\u20137.","journal-title":"Kardiol Pol"},{"issue":"6","key":"2691_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ejechocard\/jep048","volume":"10","author":"M Kamalesh","year":"2009","unstructured":"Kamalesh M, Ng C, El Masry H, Eckert G, Sawada S. Does diabetes accelerate progression of calcific aortic stenosis? Eur J Echocardiogr. 2009;10(6):723\u20135.","journal-title":"Eur J Echocardiogr"},{"issue":"3","key":"2691_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10753-011-9384-7","volume":"35","author":"J Natorska","year":"2012","unstructured":"Natorska J, Wypasek E, Grudzie\u0144 G, Sobczyk D, Marek G, Filip G, et al. Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation. 2012;35(3):834\u201340.","journal-title":"Inflammation"},{"issue":"1","key":"2691_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","volume":"19","author":"M Kopytek","year":"2020","unstructured":"Kopytek M, Z\u0105bczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2691_CR9","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s00125-021-05545-w","volume":"64","author":"M Kopytek","year":"2021","unstructured":"Kopytek M, Mazur P, Z\u0105bczyk M, Undas A, Natorska J. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-\u03baB and more pronounced valve calcification. Diabetologia. 2021;64(11):2562\u201374.","journal-title":"Diabetologia"},{"key":"2691_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exger.2014.05.001","volume":"59","author":"B Hofmann","year":"2014","unstructured":"Hofmann B, Yakobus Y, Indrasari M, Nass N, Santos AN, Kraus FB, et al. RAGE influences the development of aortic valve stenosis in mice on a high fat diet. Exp Gerontol. 2014;59:13\u201320.","journal-title":"Exp Gerontol"},{"issue":"13","key":"2691_CR11","doi-asserted-by":"publisher","first-page":"e015261","DOI":"10.1161\/JAHA.119.015261","volume":"9","author":"K Saku","year":"2020","unstructured":"Saku K, Tahara N, Takaseya T, Otsuka H, Takagi K, Shojima T, et al. Pathological role of receptor for advanced glycation end products in calcified aortic valve stenosis. J Am Heart Assoc. 2020;9(13):e015261.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2691_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12933-024-02160-y","volume":"23","author":"X Hu","year":"2024","unstructured":"Hu X, Feng D, Zhang Y, Wang C, Chen Y, Niu G, et al. Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1):73.","journal-title":"Cardiovasc Diabetol"},{"key":"2691_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1253\/circj.CJ-16-1166","volume":"81","author":"P Mazur","year":"2017","unstructured":"Mazur P, Wypasek E, Gaw\u0119da B, Sobczyk D, Kapusta P, Natorska J, et al. Stenotic bicuspid and tricuspid aortic valves\u2014micro-computed tomography and biological indices of calcification. Circ J. 2017;81:1043\u201350.","journal-title":"Circ J"},{"issue":"Suppl 1","key":"2691_CR14","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2 Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"key":"2691_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561\u2013632.","journal-title":"Eur Heart J"},{"issue":"17","key":"2691_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.2014.14681","volume":"312","author":"TM Maddox","year":"2014","unstructured":"Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754\u201363.","journal-title":"JAMA"},{"key":"2691_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1364\/JOSAA.1.000612","volume":"1","author":"LA Feldkamp","year":"1984","unstructured":"Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Soc Am. 1984;1:612\u20139.","journal-title":"J Opt Soc Am"},{"issue":"3","key":"2691_CR18","first-page":"320","volume":"21","author":"S Chitsaz","year":"2012","unstructured":"Chitsaz S, Gundiah N, Blackshear C, Tegegn N, Yan KS, Azadani AN, et al. Correlation of calcification on excised aortic valves by micro-computed tomography with severity of aortic stenosis. J Heart Valve Dis. 2012;21(3):320\u20137.","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"2691_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.5114\/aoms\/152921","volume":"18","author":"P Dobrowolski","year":"2022","unstructured":"Dobrowolski P, Prejbisz A, Kury\u0142owicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome\u2014a new definition and management guidelines: a joint position paper by the e Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, \u201cClub 30\u201d Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci. 2022;18(5):1133\u201356.","journal-title":"Arch Med Sci"},{"issue":"12","key":"2691_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/RLI.0000000000000897","volume":"57","author":"V Mergen","year":"2022","unstructured":"Mergen V, Sartoretti T, Baer-Beck M, Schmidt B, Petersilka M, Wildberger JE, et al. Ultra-High-resolution coronary CT angiography with photon-counting detector CT: feasibility and image characterization. Invest Radiol. 2022;57(12):780\u20138.","journal-title":"Invest Radiol"},{"issue":"10","key":"2691_CR21","doi-asserted-by":"publisher","first-page":"e017112","DOI":"10.1161\/CIRCIMAGING.124.017112","volume":"17","author":"M Vecsey-Nagy","year":"2024","unstructured":"Vecsey-Nagy M, Tremamunno G, Schoepf UJ, Gnasso C, Zsarn\u00f3czay E, Fink N, et al. Intraindividual comparison of Ultrahigh-Spatial-Resolution Photon-Counting detector CT and Energy-Integrating detector CT for coronary stenosis measurement. Circ Cardiovasc Imaging. 2024;17(10):e017112.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2691_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-024-03273-x","author":"SP Sharma","year":"2024","unstructured":"Sharma SP, Verhemel S, Hirsch A, van der Bie J, Dijkshoorn ML, Daemen J, et al. Diagnostic performance of high and ultra-high-resolution photon counting CT for detection of coronary artery disease in patients evaluated for transcatheter aortic valve implantation. Int J Cardiovasc Imaging. 2024. https:\/\/doi.org\/10.1007\/s10554-024-03273-x. Epub ahead of print.","journal-title":"Int J Cardiovasc Imaging"},{"key":"2691_CR23","doi-asserted-by":"publisher","first-page":"758793","DOI":"10.3389\/fcvm.2021.758793","volume":"8","author":"Y Yi","year":"2021","unstructured":"Yi Y, Xu C, Xu M, Yan J, Li YY, Wang J, et al. Diagnostic improvements of deep learning-based image reconstruction for assessing calcification-related obstructive coronary artery disease. Front Cardiovasc Med. 2021;8:758793.","journal-title":"Front Cardiovasc Med"},{"key":"2691_CR24","doi-asserted-by":"publisher","first-page":"812692","DOI":"10.3389\/fcvm.2021.812692","volume":"8","author":"K Han","year":"2022","unstructured":"Han K, Shi D, Yang L, Xie M, Zhong R, Wang Z, et al. Diabetes is associated with rapid progression of aortic stenosis: A Single-Center retrospective cohort study. Front Cardiovasc Med. 2022;8:812692.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2691_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0002-9149(01)01821-5","volume":"88","author":"WS Aronow","year":"2001","unstructured":"Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of Statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88(6):693\u20135.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2691_CR26","doi-asserted-by":"publisher","first-page":"17835","DOI":"10.1038\/s41598-018-36388-y","volume":"8","author":"JL Go","year":"2018","unstructured":"Go JL, Prem K, Al-Hijji MA, Qin Q, Noble C, Young MD, et al. Experimental metabolic syndrome model associated with mechanical and structural degenerative changes of the aortic valve. Sci Rep. 2018;8(1):17835.","journal-title":"Sci Rep"},{"key":"2691_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.carpath.2018.02.002","volume":"34","author":"M Scatena","year":"2018","unstructured":"Scatena M, Jackson MF, Speer MY, Leaf EM, Wallingford MC, Giachelli CM. Increased calcific aortic valve disease in response to a diabetogenic, procalcific diet in the LDLr-\/-ApoB100\/100 mouse model. Cardiovasc Pathol. 2018;34:28\u201337.","journal-title":"Cardiovasc Pathol"},{"key":"2691_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-025-02634-7","volume":"24","author":"A Wang","year":"2025","unstructured":"Wang A, \u00d6stgren CJ, Norhammar A, Kylhammar D, Jernberg T, Lind L, et al. Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population. Cardiovasc Diabetol. 2025;24:105.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2691_CR29","doi-asserted-by":"publisher","first-page":"lvac001","DOI":"10.1093\/ejendo\/lvac001","volume":"188","author":"Y Cho","year":"2023","unstructured":"Cho Y, Chang Y, Ryu S, Kim Y, Jung HS, Kang J, et al. Persistence or regression of prediabetes and coronary artery calcification among adults without diabetes. Eur J Endocrinol. 2023;188(1):lvac001.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2691_CR30","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1097\/CCM.0b013e318283d124","volume":"41","author":"PE Marik","year":"2013","unstructured":"Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care Med. 2013;41(6):e93\u20134.","journal-title":"Crit Care Med"},{"issue":"3","key":"2691_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/dmrr.427","volume":"20","author":"A Sch\u00f6lin","year":"2004","unstructured":"Sch\u00f6lin A, Siegbahn A, Lind L, Berne C, Sundkvist G, Bj\u00f6rk E, et al. Diabetes incidence study in Sweden group. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes. Diabetes Metab Res Rev. 2004;20(3):205\u201310.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2691_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12902-021-00925-0","volume":"22","author":"MS Ellulu","year":"2022","unstructured":"Ellulu MS, Samouda H. Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):16.","journal-title":"BMC Endocr Disord"},{"key":"2691_CR33","doi-asserted-by":"crossref","unstructured":"Lind V, Lundman P, Friberg L, Talb\u00e4ck M, Hammar N, Walldius G et al. Dysglycaemia and incident aortic stenosis: a cohort study. Heart. 2025:heartjnl\u20132024.","DOI":"10.1136\/heartjnl-2024-325150"},{"key":"2691_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00726-003-0017-9","volume":"25","author":"SR Thorpe","year":"2003","unstructured":"Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids. 2003;25:275\u201381.","journal-title":"Amino Acids"},{"key":"2691_CR35","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","volume":"280","author":"MP Wautier","year":"2001","unstructured":"Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab. 2001;280:E685\u201394.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2691_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mvr.2009.12.005","volume":"80","author":"ME Francis-Sedlak","year":"2010","unstructured":"Francis-Sedlak ME, Moya ML, Huang JJ, Lucas SA, Chandrasekharan N, Larson JC, et al. Collagen glycation alters neovascularization in vitro and in vivo. Microvasc Res. 2010;80:3\u20139.","journal-title":"Microvasc Res"},{"issue":"1","key":"2691_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"VP Singh","year":"2014","unstructured":"Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1\u201314.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"6","key":"2691_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.matbio.2010.04.004","volume":"29","author":"A Yuen","year":"2010","unstructured":"Yuen A, Laschinger C, Talior I, Lee W, Chan M, Birek J, et al. Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol. 2010;29(6):537\u201348.","journal-title":"Matrix Biol"},{"issue":"10","key":"2691_CR39","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.jbiomech.2011.04.026","volume":"44","author":"SF Kemeny","year":"2011","unstructured":"Kemeny SF, Figueroa DS, Andrews AM, Barbee KA, Clyne AM. Glycated collagen alters endothelial cell actin alignment and nitric oxide release in response to fluid shear stress. J Biomech. 2011;44(10):1927\u201335.","journal-title":"J Biomech"},{"issue":"6","key":"2691_CR40","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1159\/000226225","volume":"46","author":"T Tanikawa","year":"2009","unstructured":"Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK. J Vasc Res. 2009;46(6):572\u201380.","journal-title":"J Vasc Res"},{"issue":"3","key":"2691_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/147323000903700329","volume":"37","author":"X Ren","year":"2009","unstructured":"Ren X, Shao H, Wei Q, Sun Z, Liu N. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res. 2009;37(3):847\u201354.","journal-title":"J Int Med Res"},{"issue":"1","key":"2691_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13098-022-00873-2","volume":"14","author":"T Jiang","year":"2022","unstructured":"Jiang T, Zhang Y, Dai F, Liu C, Hu H, Zhang Q. Advanced glycation end products and diabetes and other metabolic indicators. Diabetol Metab Syndr. 2022;14(1):104.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"2691_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00395-012-0306-0","volume":"107","author":"F Li","year":"2012","unstructured":"Li F, Cai Z, Chen F, Shi X, Zhang Q, Chen S, et al. Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. Basic Res Cardiol. 2012;107(6):306.","journal-title":"Basic Res Cardiol"},{"key":"2691_CR44","doi-asserted-by":"publisher","first-page":"18822","DOI":"10.1038\/srep18822","volume":"6","author":"Y Peng","year":"2016","unstructured":"Peng Y, Kim JM, Park HS, Yang A, Islam C, Lakatta EG, et al. AGE-RAGE signal generates a specific NF-\u03baB rela barcode that directs collagen I expression. Sci Rep. 2016;6:18822.","journal-title":"Sci Rep"},{"issue":"11","key":"2691_CR45","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1111\/jcmm.15277","volume":"24","author":"M Vadana","year":"2020","unstructured":"Vadana M, Cecoltan S, Ciortan L, Macarie RD, Tucureanu MM, Mihaila AC, et al. Molecular mechanisms involved in high glucose-induced valve calcification in a 3D valve model with human valvular cells. J Cell Mol Med. 2020;24(11):6350\u201361.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2691_CR46","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3390\/polym12122786","volume":"12","author":"L Ciortan","year":"2020","unstructured":"Ciortan L, Macarie RD, Cecoltan S, Vadana M, Tucureanu MM, Mihaila AC, et al. Chronic high glucose concentration induces inflammatory and remodeling changes in valvular endothelial cells and valvular interstitial cells in a gelatin methacrylate 3D model of the human aortic valve. Polym (Basel). 2020;12(12):2786.","journal-title":"Polym (Basel)"},{"issue":"17","key":"2691_CR47","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1001\/jama.2014.13959","volume":"312","author":"JG Smith","year":"2014","unstructured":"Smith JG, Luk K, Schulz CA, Engert JC, Do R, Hindy G, et al. Cohorts for heart and aging research in genetic epidemiology (CHARGE) extracoronary calcium working group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA. 2014;312(17):1764\u201371.","journal-title":"JAMA"},{"issue":"4","key":"2691_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/HCO.0000000000000300","volume":"31","author":"C Yeang","year":"2016","unstructured":"Yeang C, Wilkinson MJ, Tsimikas S. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol. 2016;31(4):440\u201350.","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"2691_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306\u201314.","journal-title":"Circulation"},{"issue":"11","key":"2691_CR50","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.amjcard.2019.08.037","volume":"124","author":"AM Greve","year":"2019","unstructured":"Greve AM, Bang CN, Boman K, Egstrup K, Kes\u00e4niemi YA, Ray S, et al. Relation of lipid-lowering therapy to need for aortic valve replacement in patients with asymptomatic mild to moderate aortic stenosis. Am J Cardiol. 2019;124(11):1736\u201340.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2691_CR51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1088\/0967-3334\/21\/3\/306","volume":"21","author":"DR Boughner","year":"2000","unstructured":"Boughner DR, Thornton M, Dunmore-Buyze J, Holdsworth DW. The radiographic quantitation of aortic valve calcification: implications for assessing bioprosthetic valve calcification in vitro. Physiol Meas. 2000;21(3):409\u201316.","journal-title":"Physiol Meas"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02691-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T16:45:36Z","timestamp":1742575536000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02691-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02691-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}